IDEXX Cash And Short Term Investments vs Non Current Assets Total Analysis
IDXX Stock | USD 496.95 2.82 0.56% |
IDEXX Laboratories financial indicator trend analysis is infinitely more than just investigating IDEXX Laboratories recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether IDEXX Laboratories is a good investment. Please check the relationship between IDEXX Laboratories Cash And Short Term Investments and its Non Current Assets Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.
Cash And Short Term Investments vs Non Current Assets Total
Cash And Short Term Investments vs Non Current Assets Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of IDEXX Laboratories Cash And Short Term Investments account and Non Current Assets Total. At this time, the significance of the direction appears to have weak relationship.
The correlation between IDEXX Laboratories' Cash And Short Term Investments and Non Current Assets Total is 0.31. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of IDEXX Laboratories, assuming nothing else is changed. The correlation between historical values of IDEXX Laboratories' Cash And Short Term Investments and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of IDEXX Laboratories are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Cash And Short Term Investments i.e., IDEXX Laboratories' Cash And Short Term Investments and Non Current Assets Total go up and down completely randomly.
Correlation Coefficient | 0.31 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Cash And Short Term Investments
Short Term Investments is an account in the current assets section of IDEXX Laboratories balance sheet. This account contains IDEXX Laboratories investments that will expire within one year. These investments include stocks and bonds that can be liquidated by IDEXX Laboratories fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Most indicators from IDEXX Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into IDEXX Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.At this time, IDEXX Laboratories' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 44.60 in 2024, whereas Selling General Administrative is likely to drop slightly above 171.1 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.9B | 2.0B | 2.2B | 2.3B | Total Revenue | 3.2B | 3.4B | 3.7B | 3.8B |
IDEXX Laboratories fundamental ratios Correlations
Click cells to compare fundamentals
IDEXX Laboratories Account Relationship Matchups
High Positive Relationship
High Negative Relationship
IDEXX Laboratories fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.8B | 2.3B | 2.4B | 2.7B | 3.3B | 3.4B | |
Other Current Liab | 322.9M | 415.6M | 458.9M | 433.7M | 478.7M | 502.6M | |
Total Current Liabilities | 725.3M | 582.8M | 763.6M | 1.2B | 951.5M | 999.1M | |
Total Stockholder Equity | 177.5M | 632.1M | 690.0M | 608.7M | 1.5B | 1.6B | |
Property Plant And Equipment Net | 533.8M | 555.2M | 587.7M | 649.5M | 702.2M | 737.3M | |
Net Debt | 897.3M | 524.6M | 779.2M | 1.2B | 493.9M | 255.9M | |
Retained Earnings | 1.6B | 2.2B | 2.9B | 3.6B | 4.4B | 4.7B | |
Accounts Payable | 72.2M | 74.6M | 116.1M | 110.2M | 110.6M | 116.2M | |
Cash | 90.3M | 383.9M | 144.5M | 112.5M | 453.9M | 476.6M | |
Non Current Assets Total | 1.2B | 1.2B | 1.5B | 1.6B | 1.8B | 1.9B | |
Non Currrent Assets Other | 299.0M | 337.2M | 397.4M | 425.6M | 448.5M | 470.9M | |
Cash And Short Term Investments | 90.3M | 383.9M | 144.5M | 112.5M | 453.9M | 476.6M | |
Net Receivables | 269.3M | 331.4M | 368.3M | 400.6M | 457.4M | 480.3M | |
Common Stock Shares Outstanding | 87.5M | 86.7M | 86.6M | 84.6M | 84.0M | 94.9M | |
Liabilities And Stockholders Equity | 1.8B | 2.3B | 2.4B | 2.7B | 3.3B | 3.4B | |
Inventory | 195.0M | 209.9M | 269.0M | 367.8M | 380.3M | 399.3M | |
Other Current Assets | 125.0M | 137.5M | 173.8M | 220.5M | 203.6M | 213.8M | |
Other Stockholder Equity | (1.4B) | (1.5B) | (2.2B) | (2.9B) | (2.9B) | (2.8B) | |
Total Liab | 1.7B | 1.7B | 1.7B | 2.1B | 1.8B | 1.9B | |
Total Current Assets | 679.6M | 1.1B | 955.7M | 1.1B | 1.5B | 1.6B | |
Non Current Liabilities Total | 929.3M | 1.1B | 983.6M | 902.2M | 823.8M | 865.0M | |
Intangible Assets | 58.5M | 52.5M | 99.0M | 97.7M | 84.5M | 74.5M | |
Short Long Term Debt Total | 987.7M | 908.5M | 923.7M | 1.3B | 947.9M | 995.3M | |
Short Term Debt | 288.8M | 50.0M | 148.5M | 654.0M | 325.0M | 208.6M | |
Property Plant And Equipment Gross | 614.5M | 646.3M | 1.3B | 649.5M | 1.6B | 1.7B | |
Accumulated Other Comprehensive Income | (46.2M) | (53.6M) | (53.5M) | (77.8M) | (71.2M) | (67.6M) | |
Common Stock Total Equity | 10.6M | 10.6M | 10.7M | 10.7M | 12.3M | 9.0M | |
Common Stock | 10.6M | 10.6M | 10.7M | 10.7M | 10.8M | 9.2M | |
Other Assets | 240.2M | 676.7M | 893.9M | 387.5M | 445.6M | 467.9M | |
Treasury Stock | (2.3B) | (2.6B) | (2.8B) | (3.6B) | (3.2B) | (3.1B) | |
Property Plant Equipment | 533.8M | 555.2M | 587.7M | 649.5M | 746.9M | 784.2M | |
Current Deferred Revenue | 41.5M | 42.6M | 40.0M | 37.9M | 37.2M | 25.0M | |
Good Will | 239.7M | 243.3M | 359.3M | 361.8M | 366.0M | 206.0M | |
Other Liab | 162.8M | 220.5M | 208.4M | 106.6M | 122.6M | 83.3M | |
Long Term Debt | 698.9M | 858.5M | 775.2M | 694.4M | 622.9M | 380.8M | |
Net Tangible Assets | (120.7M) | 336.2M | 690.0M | 149.3M | 134.3M | 141.1M | |
Noncontrolling Interest In Consolidated Entity | 264K | 280K | 352K | 707K | 813.1K | 853.7K | |
Retained Earnings Total Equity | 1.6B | 2.2B | 2.9B | 3.6B | 4.1B | 4.3B | |
Long Term Debt Total | 698.9M | 858.5M | 775.2M | 694.4M | 798.5M | 502.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether IDEXX Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IDEXX Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Idexx Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Idexx Laboratories Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for IDEXX Stock analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.102 | Earnings Share 10.34 | Revenue Per Share 44.828 | Quarterly Revenue Growth 0.071 | Return On Assets 0.2263 |
The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.